Bridge therapy or standard treatment for urgent surgery after coronary stent implantation: Analysis of 314 patients

Vascular Pharmacology

Volumn 80, Issue , 2016, Pages 85-90

  De Servi, Stefano ^a   Morici, Nuccia ^b   Boschetti, Enrico ^c   Rossini, Roberta ^d   Martina, Paola ^e   Musumeci, Giuseppe ^d   D'Urbano, Maurizio ^e   Lazzari, Ludovico ^c   La Vecchia, Carlo ^f   Senni, Michele ^d   Klugmann, Silvio ^b   Savonitto, Stefano ^g  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c University Hospital   (Italy)

^d Dipartimento Cardiovascolare   (Italy)

^e Civic Hospital   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g A MANZONI HOSPITAL   (Italy)

Author keywords

ADP receptors; Coronary syndrome; Platelet glycoproteins

Indexed keywords

PURINERGIC P2Y RECEPTOR ANTAGONIST; TIROFIBAN; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR; TYROSINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY STENTING; DISEASE ASSOCIATION; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STENT THROMBOSIS; TREATMENT OUTCOME; VERY ELDERLY; AMBULATORY CARE; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; BLOOD VESSEL TRANSPLANTATION; CORONARY STENOSIS; METABOLISM; POSTOPERATIVE HEMORRHAGE; PROCEDURES;

AMBULATORY CARE; ASPIRIN; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY STENOSIS; HUMANS; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POSTOPERATIVE HEMORRHAGE; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, OPERATIVE; TYROSINE;

EID: 84949643826     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2015.11.085     Document Type: Article

References (29)

1. Windecker S., Kolh P., Alfonso F., et al. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 2014 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J. 2014, 35:2541-2619.
2. Ferreira-González I., Marsal J.R., Ribera A., et al. Double antiplatelet therapy after drug-eluting stent implantation: risk associated with discontinuation within the first year. J. Am. Coll. Cardiol. 2012, 60:1333-1339.
3. Collet J.P., Montalescot G., Blanchet B., et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 2004, 110:2361-2367.
4. Berger P.B., Kleiman N.S., Pencina M.J., et al. EVENT Investigators. Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. J. Am. Coll. Cardiol. Intv. 2010, 3:920-927.
5. Cruden N.L., Harding S.A., Flapan A.D., et al. Scottish Coronary Revascularisation Register Steering Committee. Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery. Circ. Cardiovasc. Interv. 2010, 3:236-242.
6. Gandhi N.K., Abdel-Karim A.R., Banerjee S., et al. Frequency and risk of noncardiac surgery after drug-eluting stent implantation. Catheter. Cardiovasc. Interv. 2011, 77:972-976.
7. Rossini R., Capodanno D., Lettieri C., et al. Prevalence, predictors,and long-term prognosis of premature discontinuation of oral antiplatelet therapy after drug eluting stent implantation. Am. J. Cardiol. 2011, 107:186-194.
8. Parolari A., Mussoni L., Frigerio M., et al. Increased prothrombotic state lasting as long as one month after on-pump and off-pump coronary surgery. J. Thorac. Cardiovasc. Surg. 2005, 130:303-308.
9. Brilakis E.S., Banerjee S., Berger P.B. Perioperative management of patients with coronary stents. J. Am. Coll. Cardiol. 2007, 49:2145-2150.
10. Wijeysundera D.N., Wijeysundera H.C., Yun L., et al. Risk of elective major noncardiac surgery after coronary stent insertion: a population-based study. Circulation 2012, 126:1355-1362.
11. Hawn M.T., Graham L.A., Richman J.S., et al. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA 2013, 210:1462-1472.
12. van Kuijk J.P., Flu W.J., Schouten O., et al. Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents. Am. J. Cardiol. 2009, 104:1229-1234.
13. Savonitto S., D'Urbano M., Caracciolo M., et al. Urgent surgery in patients with a recently implanted coronary drug-eluting stent: a phase II study of 'bridging' antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel. Br. J. Anaesth. 2010, 104:285-291.
14. Savonitto S., Caracciolo M., Cattaneo M., et al. Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery. J. Thromb. Haemost. 2011, 9:2133-2142.
15. Brilakis E.S., Cohen D.J., Kleiman N.S., et al. Incidence and clinical outcome of minor surgery in the year after drug-eluting stent implantation: results from the evaluation of drug-eluting stents and ischemic events registry. Am. Heart J. 2011, 161:360-366.
16. Rao A.K., Pratt C., Berke A., et al. Thrombolysis in myocardial infarction (TIMI) trial-phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J. Am. Coll. Cardiol. 1988, 11:1-11.
17. Mauri L., Hsieh W., Massaro J.M., et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N. Engl. J. Med. 2007, 356:1020-1029.
18. Abadie A., Imbens G.W. Large sample properties of matching estimators for average treatment effects. Econometrica 2006, 74:235-267.
19. Godet G., Le Manach Y., Lesache F., et al. Drug-eluting stent thrombosis in patients undergoing non-cardiac surgery: is it always a problem?. Br. J. Anaesth. 2008, 100:472-477.
20. Morici N., Moja L., Rosato V., et al. Bridge with intravenous antiplatelet therapy during temporary withdrawal of oral agents for surgical procedures: a systematic review. Intern. Emerg. Med. 2014, 9:225-235.
21. Marcos E.G., Da Fonseca A.C., Hofma S.H. Bridging therapy for early surgery in patients on dual antiplatelet therapy after drug-eluting stent implantation. Neth. Hear. J. 2011, 19:412-417.
22. Ben Morrison T., Horst B.M., Brown M.J., et al. Bridging with glycoprotein IIb/IIIa inhibitors for peri-procedural management of antiplatelet therapy in patients with drug eluting stents. Catheter. Cardiovasc. Interv. 2012, 79:575-582.
23. Capodanno D., Angiolillo D.J. Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery. Circulation 2013, 128:2785-2798.
24. Rassi A.N., Blackstone E., Militello M.A., et al. Safety of "bridging" with eptifibatide for patients with coronary stents before cardiac and non-cardiac surgery. Am. J. Cardiol. 2012, 110:485-490.
25. Alshawabkeh L.I., Prasad A., Lenkovsky F., Makary L.F., Kandil E.S., Weideman R.A., et al. Outcomes of a preoperative "bridging" strategy with glycoproteib IIb/IIIa inhibitors to porevent perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration. EuroIntervention 2013, 9:204-211.
26. Rossini R., Musumeci G., Oltrona Visconti L., et al. Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies. EuroIntervention 2014, 10:38-46.
27. Rossini R., Musumeci G., Capodanno D., et al. Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery. Thromb. Haemost. 2015, 113:272-282.
28. Angiolillo D.J., Firstenberg M.S., Price M.J., BRIDGE Investigators, et al. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial. JAMA 2012, 307:265-274.
29. Kristensen S.D., Knuuti J., Saraste A., et al. Authors/Task Force Members. 2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management: the Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur. Heart J. 2014, 35:2383-2431.